Gabapentin Capsule
Product Images NDC 71205-064

Product Visual Gallery

This gallery contains 11 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71205-064). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71205 064 72

This is a description of a medication called Gabapentin, which is prescribed only. It comes in orange and light brown capsules with "LOGO" and *667* printed on both cap and body. The capsule contains Gabapentin, USP 400 mg. The medication guide should be dispensed separately to each patient. It is packaged by a company called Proficient Rx LP in California, USA. The medicine needs to be stored at a temperature of 20°-25°C (68°-77°F) and kept out of reach of children. Various lots and packaging numbers are also provided.*

FDA Label Image

1 (Image 1)

The given text seems to be a formula that calculates an estimated glomerular filtration rate (eGFR) based on a patient's age, weight, and serum creatinine level. eGFR is a measure of kidney function that is used to diagnose and monitor kidney disease. The formula is different for male and female patients (not shown). However, the text does not provide complete information, and the formula may not be clinically valid or appropriate for individual patient care.*

FDA Label Image

1 (Image 12)

FDA Label Image

1 (Image 2)

FDA Label Image

1 (Image 3)

FDA Label Image

1 (Image 4)

FDA Label Image

1 (Image 5)

FDA Label Image

1 (Image 6)

This appears to be a table or chart with the title "Mean Pain Score" and data related to medication dosages and study periods. It is unclear what condition the study is related to or what the pain score represents. Without additional context, it is not possible to generate a meaningful description.*

FDA Label Image

2 (Image 7)

This is a table that shows the mean pain score at different weeks in two different periods, a titration period and a fixed dose period. There were two groups taking different dosages of gabapentin (1800 mg/day and 2400 mg/day) and a placebo group. The pain score was consistently 0 in all groups.*

FDA Label Image

3 (Image 8)

FDA Label Image

4 (Image 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.